35 results on '"Jakob, Clarissa G."'
Search Results
2. Discovery of Potent Azetidine-Benzoxazole MerTK Inhibitors with In VivoTarget Engagement
3. Discovery of A-910, a Highly Potent and Orally Bioavailable Dual MerTK/Axl-Selective Tyrosine Kinase Inhibitor
4. Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
5. Author Correction: Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
6. Discovery of spirohydantoins as selective, orally bioavailable inhibitors of p300/CBP histone acetyltransferases
7. A potent erythropoietin-mimicking human antibody interacts through a novel binding site
8. The structure of dual-variable-domain immunoglobulin molecules alone and bound to antigen
9. Structure reveals function of the dual variable domain immunoglobulin (DVD-Ig™) molecule
10. Ligand association rates to the inner-variable-domain of a dual-variable-domain immunoglobulin are significantly impacted by linker design
11. Structure-based Optimization of MurF Inhibitors
12. Ion binding induces closed conformation in Psuedomonas 7A glutaminase-asparaginase (PGA): crystal structure of the PGA-SO (sub 4)(super 2-)-NH4+ complex at 1.7 angstrom resolution
13. Structure of MurF from Streptococcus pneumoniae co-crystallized with a small molecule inhibitor exhibits interdomain closure
14. Why not wild-type IDH1? Finding novel chemical matter for the forgotten isotype
15. Fragment-Based Discovery of an Apolipoprotein E4 (apoE4) Stabilizer
16. SAR of amino pyrrolidines as potent and novel protein-protein interaction inhibitors of the PRC2 complex through EED binding
17. Novel Modes of Inhibition of Wild-Type Isocitrate Dehydrogenase 1 (IDH1): Direct Covalent Modification of His315
18. Crystal structures of DPP-IV (CD26) from rat kidney exhibit flexible accommodation of peptidase-selective inhibitors
19. Abstract LB-A23: Discovery of a potent catalytic p300/CBP inhibitor that targets lineage-specific tumors
20. Erratum: The EED protein–protein interaction inhibitor A-395 inactivates the PRC2 complex
21. Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
22. The EED protein–protein interaction inhibitor A-395 inactivates the PRC2 complex
23. The SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrity
24. Discovery of A-893, A New Cell-Active Benzoxazinone Inhibitor of Lysine Methyltransferase SMYD2
25. Synthesis and structure–activity relationship of 3,4′-bispyridinylethylenes: Discovery of a potent 3-isoquinolinylpyridine inhibitor of protein kinase B (PKB/Akt) for the treatment of cancer
26. Discovery of trans-3,4′-bispyridinylethylenes as potent and novel inhibitors of protein kinase B (PKB/Akt) for the treatment of cancer: Synthesis and biological evaluation
27. A highly potent and selective farnesyltransferase inhibitor ABT-100 in preclinical studies
28. Design, synthesis, and activity of 4-quinolone and pyridone compounds as nonthiol-containing farnesyltransferase inhibitors
29. Discovery of Potent Inhibitors of Dihydroneopterin Aldolase Using CrystaLEAD High-Throughput X-ray Crystallographic Screening and Structure-Directed Lead Optimization
30. Design, Synthesis, and Biological Activity of 4-[(4-Cyano-2-arylbenzyloxy)-(3-methyl-3H-imidazol-4-yl)methyl]benzonitriles as Potent and Selective Farnesyltransferase Inhibitors
31. Aryl tetrahydropyridine inhibitors of farnesyltransferase: bioavailable analogues with improved cellular potency
32. Aryl tetrahydropyridine inhibitors of farnesyltransferase: glycine, phenylalanine and histidine derivatives
33. Crystal structure of human prostatic acid phosphatase
34. Ion Binding Induces Closed Conformation in Pseudomonas 7A Glutaminase-Asparaginase (PGA): Crystal Structure of the PGA-SO42--NH4+ Complex at 1.7 Å Resolution,
35. Crystallization and Prelimary Crystallographic Data for Formyltetrahydrofolate Synthetase from Clostridium thermoaceticum
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.